BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 3626517)

  • 1. Medullary thyroid carcinoma with thyroglobulin immunoreactivity. A special entity?
    Holm R; Sobrinho-Simões M; Nesland JM; Sambade C; Johannessen JV
    Lab Invest; 1987 Sep; 57(3):258-68. PubMed ID: 3626517
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Medullary carcinoma of the thyroid: histomorphological, histochemical and immunohistochemical analysis of twenty cases.
    Kos M; Separović V; Sarcević B
    Acta Med Croatica; 1995; 49(4-5):195-9. PubMed ID: 8630453
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mixed medullary-follicular carcinoma of the thyroid gland: a clinicopathologic variant of medullary thyroid carcinoma.
    Mizukami Y; Nonomura A; Michigishi T; Noguchi M; Ishizaki T
    Mod Pathol; 1996 Jun; 9(6):631-5. PubMed ID: 8782199
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Carcinoma of the thyroid gland with biphasic clinical course and evolution into medullary carcinoma, follicular variant. A case report and immunocytochemical demonstration of the simultaneous presence of calcitonin and thyroglobulin in neoplastic cells].
    Carlei F; Famulari A; Muzi P; Sciaratta F; Mariani P; Lomanto D; D'Alessandro M
    Minerva Chir; 1992 Apr; 47(8):773-5. PubMed ID: 1603426
    [No Abstract]   [Full Text] [Related]  

  • 5. Thyroid carcinoma with biphasic clinical course and evolution in medullary carcinoma-follicular variant. A case report and an immunocytochemical demonstration of calcitonin and thyroglobulin in the same neoplastic cells.
    Baschieri I; Ronga G; Fiorentino A; Mariani P; Carlei F
    J Nucl Med Allied Sci; 1990; 34(2):71-6. PubMed ID: 2246675
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Histologic and immunohistochemical characterization of medullary thyroid carcinoma].
    Abrosimov Aiu
    Arkh Patol; 1996; 58(4):43-8. PubMed ID: 8967865
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemistry of thyroid carcinoma--an experience with thyroglobulin and calcitonin.
    Kavishwar VS; Phatak AM; Rege JD
    Indian J Pathol Microbiol; 1998 Apr; 41(2):163-7. PubMed ID: 9670628
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A metastasizing composite carcinoma of the thyroid with distinct medullary and papillary components.
    Apel RL; Alpert LC; Rizzo A; LiVolsi VA; Asa SL
    Arch Pathol Lab Med; 1994 Nov; 118(11):1143-7. PubMed ID: 7979902
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Histopathological and immunohistochemical studies on medullary thyroid carcinoma].
    Jiang C; Tan Y; Li E
    Zhonghua Bing Li Xue Za Zhi; 1996 Dec; 25(6):332-5. PubMed ID: 9388857
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medullary and mixed medullary-papillary carcinoma of the thyroid gland.
    Macák J; Vaverková H; Dushová M; Perglerová I
    Pathologica; 1997 Jun; 89(3):317-22. PubMed ID: 9270266
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thyroid papillary carcinoma of columnar cell type: a clinicopathologic study of 16 cases.
    Wenig BM; Thompson LD; Adair CF; Shmookler B; Heffess CS
    Cancer; 1998 Feb; 82(4):740-53. PubMed ID: 9477108
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Calcitonin, calcitonin gene-related peptide, and gastrin-releasing peptide in familial thyroid medullary carcinoma.
    Månsson B; Ahrén B; Nobin A; Böttcher G; Sundler F
    Surgery; 1990 Feb; 107(2):182-6. PubMed ID: 2300897
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohistochemistry in medullary thyroid carcinoma: prognosis and distinction between hereditary and sporadic tumors.
    Franc B; Caillou B; Carrier AM; Dutrieux-Berger N; Floquet J; Houcke M; Justrabo E; Lange F; Pages A; Rigaud C
    Henry Ford Hosp Med J; 1987; 35(2-3):139-42. PubMed ID: 2891646
    [No Abstract]   [Full Text] [Related]  

  • 14. Medullary differentiation of anaplastic thyroid carcinoma.
    Nieuwenhuijzen Kruseman AC; Bosman FT; van Bergen Henegouw JC; Cramer-Knijnenburg G; Brutel de la Riviere G
    Am J Clin Pathol; 1982 May; 77(5):541-7. PubMed ID: 6177234
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunohistochemical hormone content in medullary and undifferentiated thyroid carcinoma and prognosis after surgery.
    Henninger S; Schatz H; Stracke H; Wagner U; Kracht J
    Acta Histochem; 1988; 83(1):51-6. PubMed ID: 2897752
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carcinoma of the thyroid with a mixed medullary, papillary, follicular, and undifferentiated pattern.
    Parker LN; Kollin J; Wu SY; Rypins EB; Juler GL
    Arch Intern Med; 1985 Aug; 145(8):1507-9. PubMed ID: 3896182
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary squamous-cell carcinoma of the thyroid gland: new evidence in support of follicular epithelial cell origin.
    Sahoo M; Bal CS; Bhatnagar D
    Diagn Cytopathol; 2002 Oct; 27(4):227-31. PubMed ID: 12357501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thyroid medullary carcinoma with thyroglobulin immunoreactivity in sporadic multiple endocrine neoplasia type 2-B.
    Kovacs CS; Masé RM; Kovacs K; Nguyen GK; Chik CL
    Cancer; 1994 Aug; 74(3):928-32. PubMed ID: 7913660
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of diagnostic immunohistochemistry on the recognition and management of two cases of thyroid cancer with protracted courses.
    Cramer SF; Rosenthal SN; Swinburne AJ; Lewis CL
    Arch Pathol Lab Med; 1989 Nov; 113(11):1236-8. PubMed ID: 2818148
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Normal preoperative calcitonin levels do not always exclude medullary thyroid carcinoma in patients with large palpable thyroid masses.
    Redding AH; Levine SN; Fowler MR
    Thyroid; 2000 Oct; 10(10):919-22. PubMed ID: 11081258
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.